查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465815

2024 年药物发现实验室自动化全球市场报告

Lab Automation In Drug Discovery Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

药物发现的实验室自动化市场规模预计在未来几年将强劲成长。 2028年，这一数字将以5.3%的复合年增长率成长至79.6亿美元。预测期内的预期增长是由製药公司药物管道的扩张、个人化医疗和精准治疗方法的兴起、对罕见疾病和罕见疾病药物的日益关注以及远端和分散临床试验的推动推动的。多种因素，包括需求的增加以及微流体和实验室晶片技术的出现。预测期内预计的主要趋势包括模组化和可自订自动化解决方案的普及、云端基础的资料管理和协作平台的采用、新兴市场自动化的成长以及自动化和数位技术，其中包括虚拟药物发现的兴起。利用技术以及标准化通讯协定和可互操作系统的开发。这些因素共同促进了药物发现领域实验室自动化的预期成长。

对精准医学的需求不断增长预计将推动药物发现市场实验室自动化的成长。精准医疗又称为个人化医疗，是根据个人基因、环境、生活方式的差异，制定医疗治疗和预防策略。实验室自动化在加速研究、提高实验重现性以及简化精准医学和药物发现程序方面发挥着至关重要的作用。反过来，这将导致针对个别患者开发更有效的药物和诊断方法。据个人化医疗联盟（PMC）称，到2022年10月，将有超过75,000种基因检测产品和300多种个人化药物上市，治疗各类癌症、遗传性罕见疾病以及各种慢性病。疾病和感染疾病做出反应。精准医学的需求不断增长是推动药物发现市场实验室自动化成长的关键因素。

药物发现实验室自动化市场的主要企业策略性地专注于开拓先进的解决方案，特别是快速的想法到资料解决方案，以获得竞争优势。快速想法到资料解决方案是简化的流程和平台，使个人和组织能够快速将想法和概念转化为可操作的见解和资料主导的结果。 2022 年 4 月，美国生物技术公司 Strateos Inc. 在其云端实验室自动化即即服务平台中添加了用于小分子发现的快速想法到资料解决方案。该实验室自动化工具专为药物开发中的小分子发现而设计，在按需、可扩展的 Strateos 云端实验室自动化即服务平台上运作。该平台将机器人自动化与 23 个工作单元和数百台仪器连接起来，透过先导化合物优化来推动早期先导化合物的产生。使用者可以在云端设计化合物，并使用各种技术自动组装和测试它们，包括基于细胞、生化和构效关係 (SAR) 评估。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章 市场细分

  • 药物发现领域的全球实验室自动化市场：按类型分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 自动液体处理机
  • 自动板材处理机
  • 机械臂
  • 自动仓储及收集系统
  • 其他类型
  • 全球药物发现实验室自动化市场：按组件分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 装置
  • 软体
  • 服务
  • 全球药物发现实验室自动化市场：按应用分類的绩效和预测，2018-2023、2023-2028F、2033F
  • 高通量筛检
  • 复合管理
  • 样品製备
  • 其他用途
  • 全球药物发现实验室自动化市场：最终用户的表现和预测，2018-2023、2023-2028F、2033F
  • 生物技术和製药业
  • 研究机构
  • 其他最终用户

第 7 章 区域/国家分析

  • 药物发现领域的全球实验室自动化市场：按地区分類的表现和预测，2018-2023、2023-2028F、2033F
  • 药物发现领域的全球实验室自动化市场：按国家分類的绩效和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 药物发现中的实验室自动化市场：竞争格局
  • 药物发现中的实验室自动化市场：公司简介
    • Thermo Fisher Scientific Inc.
    • Abbott Diagnostics
    • Roche Holdings Inc.
    • Beckman Coulter
    • Siemens Healthineers

第三十一章 其他重大及创新企业

  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Endress+Hauser
  • Shimadzu Corporation
  • Waters Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN
  • Beckhoff Automation GmbH & Co. KG
  • Eppendorf AG
  • Tecan Group Ltd.
  • Brooks Automation Inc.
  • Hamilton Company
  • AbCellera Biologics Inc.
  • Hudson Robotics Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r17134

Lab automation in drug discovery refers to the utilization of advanced technologies and robotics to streamline and optimize laboratory processes associated with new drug development and research. This approach aims to significantly improve the efficiency and success rate of drug discovery efforts by automating repetitive tasks and integrating sophisticated instruments and software. Automation in drug discovery laboratories can cover a wide range of activities, from high-throughput screening of compounds to data analysis and interpretation, allowing researchers to focus on more complex and creative aspects of their work.

The primary types of lab automation in drug discovery include automated liquid handlers, automated plate handlers, robotic arms, automated storage and retrieval systems, among others. Automated liquid handlers are machines specifically designed to dispense and handle liquids automatically. They are frequently employed in laboratories for precise and efficient liquid handling tasks such as pipetting and dilution. These automation solutions comprise various components, including instruments, software, and services, and find applications in high-throughput screening, compound management, sample preparation, and other processes. These technologies are utilized by various end-users, including biotechnology and pharmaceutical industries, research institutes, and others.

The lab automation in drug discovery research report is one of a series of new reports from The Business Research Company that provides lab automation in drug discovery market statistics, including the lab automation in drug discovery industry's global market size, regional shares, competitors with lab automation in drug discovery market share, detailed lab automation in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in drug discovery industry. This lab automation in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lab automation in drug discovery market size has grown strongly in recent years. It will grow from $6.13 billion in 2023 to $6.47 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion observed in the historical period can be attributed to several factors, including the increasing complexity of drug discovery processes, a demand for improved efficiency and cost reduction, a growing need for high-throughput screening capabilities, rising labor costs, and the pressure to accelerate drug development timelines. These factors collectively contributed to the growth of lab automation in drug discovery during that timeframe.

The lab automation in drug discovery market size is expected to see strong growth in the next few years. It will grow to $7.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be attributed to several factors, including the expansion of drug pipelines among pharmaceutical companies, the rise in personalized medicine and precision therapeutics, an increasing focus on rare diseases and orphan drugs, a growing demand for remote and decentralized clinical trials, and the emergence of microfluidics and lab-on-a-chip technologies. Key trends expected in the forecast period include the proliferation of modular and customizable automation solutions, the adoption of cloud-based platforms for data management and collaboration, the growth of automation in emerging markets, the rise of virtual drug discovery companies leveraging automation and digital technologies, and the development of standardized protocols and interoperable systems. These factors collectively contribute to the projected growth in lab automation in drug discovery.

The growing demand for precision medicine is anticipated to drive the growth of lab automation in the drug discovery market. Precision medicine, also known as personalized medicine, tailors medical treatment and prevention strategies based on individual variability in genes, environment, and lifestyle. Lab automation plays a pivotal role in accelerating research, enhancing experimental repeatability, and improving the efficiency of precision medicine and drug discovery procedures. This, in turn, leads to the development of more effective medicines and diagnostics tailored to individual patients. According to the Personalized Medicine Coalition (PMC) in October 2022, over 75,000 genetic testing products and 300 personalized medicines are expected to be available in the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The rising demand for precision medicine is a key driver propelling the growth of lab automation in the drug discovery market.

Prominent companies operating in the lab automation in the drug discovery market are strategically focusing on developing advanced solutions, particularly rapid idea-to-data solutions, to gain a competitive edge. A rapid idea-to-data solution refers to a streamlined process or platform enabling individuals or organizations to quickly transform ideas or concepts into actionable insights or data-driven results. In April 2022, Strateos Inc., a US-based biotechnology company, introduced a rapid idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. Specifically designed for small-molecule discovery in drug development, this lab automation tool operates on the on-demand and scalable Strateos Cloud Lab Automation-as-a-Service Platform. The platform includes linked robotic automation with 23 workcells and hundreds of instruments, facilitating early lead generation through lead optimization. Users can design compounds in the cloud and have them automatically assembled and tested using various methods such as cell-based, biochemical, and structured-activity relationship (SAR) assessments.

In March 2023, Brooks Automation, a US-based automation solution company, successfully acquired Aim Lab Automation Technologies Pty Ltd. for an undisclosed amount. This strategic acquisition aims to expand Brooks' presence in clinical diagnostics and drive technological advancements, significantly impacting lab automation in the drug discovery market. Aim Lab Automation Technologies Pty Ltd., based in Australia, provides robotic automation instrumentation and modules, along with automation solutions designed to enhance processes in drug discovery labs.

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

North America was the largest region in the lab automation in drug discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation in drug discovery market consists of revenues earned by entities by providing services such as compound screening, assay development, high-throughput screening, data analysis, and optimization of drug candidates. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in drug discovery market also includes sales of robotics and automated workstations, screening systems, plate readers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation In Drug Discovery Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab automation in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab automation in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lab automation in drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Automated Liquid Handlers; Automated Plate Handlers; Robotic Arms; Automated Storage And Retrieval Systems; Other Types
  • 2) By Component: Instruments; Software; Services
  • 3) By Application: High-Throughput Screening; Compound Management; Sample Preparation; Other Applications
  • 4) By End-User: Biotechnology And Pharmaceutical Industries; Research Institutes; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Diagnostics; Roche Holdings Inc.; Beckman Coulter; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lab Automation In Drug Discovery Market Characteristics

3. Lab Automation In Drug Discovery Market Trends And Strategies

4. Lab Automation In Drug Discovery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Lab Automation In Drug Discovery Market Size and Growth

  • 5.1. Global Lab Automation In Drug Discovery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Lab Automation In Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Lab Automation In Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lab Automation In Drug Discovery Market Segmentation

  • 6.1. Global Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Automated Liquid Handlers
  • Automated Plate Handlers
  • Robotic Arms
  • Automated Storage And Retrieval Systems
  • Other Types
  • 6.2. Global Lab Automation In Drug Discovery Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Software
  • Services
  • 6.3. Global Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • High-Throughput Screening
  • Compound Management
  • Sample Preparation
  • Other Applications
  • 6.4. Global Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biotechnology And Pharmaceutical Industries
  • Research Institutes
  • Other End-Users

7. Lab Automation In Drug Discovery Market Regional And Country Analysis

  • 7.1. Global Lab Automation In Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Lab Automation In Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lab Automation In Drug Discovery Market

  • 8.1. Asia-Pacific Lab Automation In Drug Discovery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lab Automation In Drug Discovery Market

  • 9.1. China Lab Automation In Drug Discovery Market Overview
  • 9.2. China Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lab Automation In Drug Discovery Market

  • 10.1. India Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lab Automation In Drug Discovery Market

  • 11.1. Japan Lab Automation In Drug Discovery Market Overview
  • 11.2. Japan Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lab Automation In Drug Discovery Market

  • 12.1. Australia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lab Automation In Drug Discovery Market

  • 13.1. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lab Automation In Drug Discovery Market

  • 14.1. South Korea Lab Automation In Drug Discovery Market Overview
  • 14.2. South Korea Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lab Automation In Drug Discovery Market

  • 15.1. Western Europe Lab Automation In Drug Discovery Market Overview
  • 15.2. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lab Automation In Drug Discovery Market

  • 16.1. UK Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lab Automation In Drug Discovery Market

  • 17.1. Germany Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lab Automation In Drug Discovery Market

  • 18.1. France Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lab Automation In Drug Discovery Market

  • 19.1. Italy Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lab Automation In Drug Discovery Market

  • 20.1. Spain Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lab Automation In Drug Discovery Market

  • 21.1. Eastern Europe Lab Automation In Drug Discovery Market Overview
  • 21.2. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lab Automation In Drug Discovery Market

  • 22.1. Russia Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lab Automation In Drug Discovery Market

  • 23.1. North America Lab Automation In Drug Discovery Market Overview
  • 23.2. North America Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lab Automation In Drug Discovery Market

  • 24.1. USA Lab Automation In Drug Discovery Market Overview
  • 24.2. USA Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lab Automation In Drug Discovery Market

  • 25.1. Canada Lab Automation In Drug Discovery Market Overview
  • 25.2. Canada Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lab Automation In Drug Discovery Market

  • 26.1. South America Lab Automation In Drug Discovery Market Overview
  • 26.2. South America Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lab Automation In Drug Discovery Market

  • 27.1. Brazil Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lab Automation In Drug Discovery Market

  • 28.1. Middle East Lab Automation In Drug Discovery Market Overview
  • 28.2. Middle East Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lab Automation In Drug Discovery Market

  • 29.1. Africa Lab Automation In Drug Discovery Market Overview
  • 29.2. Africa Lab Automation In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Lab Automation In Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Lab Automation In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lab Automation In Drug Discovery Market Competitive Landscape And Company Profiles

  • 30.1. Lab Automation In Drug Discovery Market Competitive Landscape
  • 30.2. Lab Automation In Drug Discovery Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Diagnostics
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holdings Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Beckman Coulter
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Siemens Healthineers
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Lab Automation In Drug Discovery Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Agilent Technologies Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Endress+Hauser
  • 31.5. Shimadzu Corporation
  • 31.6. Waters Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. QIAGEN
  • 31.9. Beckhoff Automation GmbH & Co. KG
  • 31.10. Eppendorf AG
  • 31.11. Tecan Group Ltd.
  • 31.12. Brooks Automation Inc.
  • 31.13. Hamilton Company
  • 31.14. AbCellera Biologics Inc.
  • 31.15. Hudson Robotics Inc.

32. Global Lab Automation In Drug Discovery Market Competitive Benchmarking

33. Global Lab Automation In Drug Discovery Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lab Automation In Drug Discovery Market

35. Lab Automation In Drug Discovery Market Future Outlook and Potential Analysis

  • 35.1 Lab Automation In Drug Discovery Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Lab Automation In Drug Discovery Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Lab Automation In Drug Discovery Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer